Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $103.8 million versus the consensus estimate of $105.4 million.

GUIDANCE:

Ironwood Pharma sees FY2021 revenue of $390-410 million, versus the consensus of $408 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.